Przejdź do zawartości
Merck

An essential role for gp130 in neointima formation following arterial injury.

Circulation research (2007-02-27)
Dong Wang, Zhimin Liu, Quanyi Li, Manjula Karpurapu, Venkatesh Kundumani-Sridharan, Huiqing Cao, Nagadhara Dronadula, Farhan Rizvi, Arun K Bajpai, Chunxiang Zhang, Gerhard Müller-Newen, Kevin W Harris, Gadiparthi N Rao
ABSTRAKT

Interleukin (IL)-6 induced vascular smooth muscle cell (VSMC) motility in a dose-dependent manner. In addition, IL-6 stimulated tyrosine phosphorylation of gp130, resulting in the recruitment and activation of STAT-3. IL-6-induced VSMC motility was found to be dependent on activation of gp130/STAT-3 signaling. IL-6 also induced cyclin D1 expression in a time- and gp130/STAT-3-dependent manner in VSMCs. Suppression of cyclin D1 levels via the use of its small interfering RNA molecules inhibited IL-6-induced VSMC motility. Furthermore, balloon injury induced IL-6 expression both at mRNA and protein levels in rat carotid artery. Balloon injury also caused increased STAT-3 phosphorylation and cyclin D1 expression, leading to smooth muscle cell migration from the media to the intimal region. Blockade of gp130/STAT-3 signaling via adenovirus-mediated expression of dngp130 or dnSTAT-3 attenuated balloon injury-induced STAT-3 phosphorylation and cyclin D1 induction, resulting in reduced smooth muscle cell migration from media to intima and decreased neointima formation. Together, these observations for the first time suggest that IL-6/gp130/STAT-3 signaling plays an important role in vascular wall remodeling particularly in the settings of postangioplasty and thereby in neointima formation.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Anti-Nuclei & Chromosomes Antibody, histone H1 protein, clone 1415-1, clone 1415-1, Chemicon®, from mouse